Introduction:
Today all over the world requirements to drug quality have become more and more strict and its evaluation is one of the most important tasks. Usually input quality control of medicines and other groups of goods is carried out organoleptically (mainly visually) by authorized persons of pharmaceutical establishments. Primary packaging is one of the most critical components in this process, because it strongly influences on possibility of visual control of goods and, of coarse, it should be transparent.
Aim:
The aim of this article was to analyze primary packaging of some drugs and possibility of their identification and quality evaluation.
Materials and Methods:
Objects of this study were primary packages of 65 randomly taken drugs produced by some leading manufacturers in different dosage forms. Inspection analysis of quality of the researched medicinal products was provided in 8 steps: checking of the accompanying documents, checking quantity of the goods, organoleptic control of packaging, checking of labeling, checking of barcodes, checking of completeness, visual control of a product, composing of documentation for acceptance of the goods.
Results and Conclusion:
All investigated drugs passed the first 6 stages of inspection analysis positively. 46 samples among 65 (or 71%) could not be visually controlled (stage 7) and their appearance was impossible to check because of non-transparency of the containers. If in terms of dosage forms 53% of studied tablet drugs, 88% of eye drops and 100% of suppositories can not be evaluated visually.
Organization for Economic Cooperation and Development (OECD). The economic im-pact of counterfeiting and piracy, 2008.
Woods K. Anti counterfeiting strategy. Medicines and healthcare products regulatory agency (MHRA) UK 2007-2010. p. 1-42.
Swaminath G. Faking it-II: Countering and preventing counterfeiting of drugs. Indian J Psychiatry. 2009;51:9-11.
Counterfeit medicines. QA counterfeit. World Health Organization (WHO) 2009. Avail-able from: http://www.who.int/medicines/services/counterfeit/faqs/QACounterfeit-october 2009.pdf.
Shah RY, Prajapati PN, Agrawal YK. Anticounterfeit packaging technologies. J. Adv. Pharm. Tech. Res. 2010;1(4):368-373. Available from: http://www.japtr.org
Benbasat AY. A survey of current optical security techniques. Massachusetts: MIT Media Lab; 1999. p. 1-20.
Deisingh AK. Pharmaceutical counterfeiting. Tutorial Review. The Analyst. The Royal society of chemistry. 2005;130:271-9. Available from: http://www.rsc.org/analyst.
Jotcham R. Understanding and evaluating security technologies for pharmaceuticals, in combating Pharmaceutical fraud and counterfeiting. SMI conference documentation. London: SMI publishing; 2003.
Ustanso A. RFID technology: A Paradigm shift in business. In: Durmuşoğlu MB, Dr. Cengiz K, Dessouky MI, Süer GA, Eid S, editors. Proceedings of the 35th International Confer-ence on Computers and Industrial Engineering; 2005 June 19-22; Istanbul: Istanbul Technical University; 2005. p. 2065-70.
Choi SH, Poon CH. An RFID based anti counterfeiting system IAENG. Int J Comput Sci. 2008;35:12.
Koroneos G. FDA opens door to RFID packaging. Pharm Technol. 2004;28:17.
Mehta R. Packaging professional magazine. Biometric fingerprints for anti counterfeiting. 2007. Available from: http://www.iom3.org/news/taking-fingerprints.
Vetiutneva NA, Ubogov SG, Budnikova TN, Pilipchuk LB, Fedorova LA, Todorova VI, et al. The normative legal adjusting in the sector of the quality assurance of medicinal products in Ukraine: retrospective analysis. Pharmaceutical Journal. 2013;4:9-16. (in Ukrainian).
Medicine remedies. Packing, marking, transportation and storage, GOST 17768-90 (January 01, 1992). Moscow: Publishing House of Standards; 1991. (in Russian).
Demyanenko VG, Afanasyeva VA, Proskochilo AV, Breusova SV. Medical and Pharmaceutical Commodity Science, practical handbook. Prof. Demyanenko VG, editor. Kyiv: Medicina; 2010. (in Russian).
Vetiutneva NA, Ubogov SG, Pilipchuk LB, Budnikova TN, Fedorova LA, Todorova VI, et al. The modern state and development trends of the normative legal adjusting in the sector of the quality assurance of medicinal products. Pharmaceutical Journal. 2014;3:66-72. (in Ukrainian).
On storage organization of different groups of medicines and medical devices in pharmacies, Order of Ministry of Public Health of Ukraine No. 44 (March 16, 1993). (in Ukrainian).
On approval of Instruction on quality control of medicinal products in wholesale and re-tail trade, Order of Ministry of Public Health of Ukraine No. 436 (October 30, 2001). Available from: http://zakon.rada.gov.ua/laws/show/z0107-02. (in Ukrainian).
On medical products, Law of Ukraine No. 123/96ВР (April 04, 1996). Available from: http://zakon3.rada.gov.ua/laws/show/123/96-вр. (in Ukrainian).
Legal acts of Ukraine. Available from: http://mozdocs.kiev.ua. (in Ukrainian).
Laws of Ukraine. Available from: http://zakon4.rada.gov.ua. (in Ukrainian).
On approval of the rules for quality control of medicinal products in wholesale and retail trade, Order of Ministry of Public Health of Ukraine No. 677 (September 29, 2014). Available from: http://www.apteka.ua/article/316075. (in Ukrainian).
State Enterprise “Scientific and Expert Pharmacopoeial Center”. State Pharmacopoeia of Ukraine. 1st ed., suppl. 1. Kharkiv: Rireg; 2004. 520 p. (in Ukrainian).
Azgaldov GG. Theory and practice of quality evaluation of goods (bases of qualimetry). Moscow: Economica; 1982. (in Russian).
Gryzodub AI, Sur SV. Problems of quality and falsification of drugs. Ukrainian Medical Journal. 2007;3(59):137-144. (in Russian).
Gryzodub AI, Sur SV, Georgiyevsky VP. Problems of quality and falsification of drugs. Pharmacom. 2007;2:6-15. (in Russian).
Ryschenko OA, Shapovalova VA, Shapovalov VV. Council of Europe Convention «On fighting falsification of medical products and similar crimes that threaten public health» as a source of development forensic pharmacy. Pharmaceutical Journal. 2013;4:39-45. (in Ukrainian).
Almakayev MS, Shevchenko IV, Shevchenko VA, Bodrenkova NA. Influence of poly-ethylene primary packaging systems on stability of parenteral drugs based on topical anesthetics. Management, economy and quality assurance in pharmacy. 2009;1(3):4-8. (in Russian).
Кrutskikh ТV, Shalamay АS. Study of the effect of packaging on quality tablets of Alto-bar during storage. Management, economy and quality assurance in pharmacy. 2015;4(42):42-44. (in Ukrainian).
Stolypin V, Gurariy L. GMP requirements to drug packaging (part 1). The Industry. 2004;2:89-92. Available from: www.erecton.ru/ publications/2-04.pdf. (in Russian).
Madsen R, Cherris R, Shabushnig J, Hunt D. Visible Particulates in Injections – A His-tory and Proposal to Revise USP Injections. USP Pharmacopeial Forum. 2009 Sept-Oct;35(5):1383-7. Available from: http://www.baipharma.com/documents/PF35-5-_StimArticle-3Chapter1VisibleParticulatesinInjections.pdf.
Tool for visual inspection of medicines. Available from: http://www.whpa.org/toolkit_beaware_inspection.pdf.
Email this article (Login required) 
